Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Despite a Mid-Stage Disappointment, This Biotech Stock Is Still in Great Shape
Despite a Mid-Stage Disappointment, This Biotech Stock Is Still in Great Shape
Despite a Mid-Stage Disappointment, This Biotech Stock Is Still in Great Shape
Submitted by
admin
on August 7, 2013 - 10:14am
Source:
Motley Fool
News Tags:
Isis Pharmaceuticals
ISIS-CRPRx
Headline:
Despite a Mid-Stage Disappointment, This Biotech Stock Is Still in Great Shape
Do Not Allow Advertisers to Use My Personal information
